期刊文献+

肺癌患者肺泡灌洗液中Survivin mRNA表达及其与吸烟相关性的临床研究 被引量:1

Study on expression of surviving mRNA and the correlation between it and smoking in bronchoalveolar lavage fluid in patients with pulmonary carcinoma
下载PDF
导出
摘要 目的研究肺癌患者支气管肺泡灌洗液(BALF)中Survivin RNA的表达与吸烟的相关性。方法收集接受纤维支气管镜检查的门诊或住院患者90例,肺癌49例(肺癌组),肺良性病变29例(对照组),正常12例(正常组)。以纤支镜灌洗留取20 mL BALF,采用荧光实时定量RT-PCR法检测Survivin mRNA的表达情况。结果肺癌组Survivin mRNA阳性表达率为92%(45/49),对照组Survivin mRNA阳性表达率为38%(11/29),正常组为17%(2/12),各组间比较均有显著性差异。肺癌组Survivin mRNA虽在鳞癌中表达较高,但与其他类型比较无显著性差异;TNM分期越晚,Survivin mRNA表达越高,有显著性差异。BALF中Survivin mRNA表达与吸烟呈正相关;肺癌组中Survivin mRNA表达与是否吸烟相关,但轻度和重度吸烟组间无显著性差异,非吸烟的良性病变者均为阴性表达。结论 BALF中Survivin mRNA表达在肺癌与肺部良性病变患者中存在显著性差异。吸烟作为一个独立因素影响Survivin mRNA表达。Survivin mRNA表达与是否吸烟有关,但与吸烟程度无相关性。排除吸烟因素的影响,BALF中的Survivin mRNA表达可作为肺癌诊断的一个参考指标,且Survivin mRNA表达量与TNM分期呈正相关,与肺癌组织学类型无相关性。 Objective It is to investigate the expression of surviving mRNA and its correlation with smoking in bronchoalveolar lavage fluid (BALF) of patients with pulmonary carcinoma. Methods 90 cases who were be examined by bronehofiherscope were selected, included 49 cases of lung cancer in lung cancer group, 29 cases of benign lung diseases (BLD) in con- trol group, and 12 cases normal subjects in normal group. The BALF in the examination was collected. The expression of survivin mRNA was measured by fluorescent real-time quantitative RT - PCR in the BALF of all groups. Results The positive expression of surviving mRNA were 92% in lung cancer group, 38% in benign lesions and 17% in normal subjects, there were significant difference among the three groups. In the lung cancer group, although surviving mRNA expression were higher in squamous cell carcinoma, but there was no significant difference compared with other types; TNM stage was later, the surviving mRNA expression was higher, there were significant correlation between them. BALF surviving mRNA expression was positively correlated with smoking, but there was no significant correlation between mild and heavy smoking; surviving mRNA expression correlated. The expression of benign and non-smoking lesions was negative. Conclusion There was significant difference in surviving mRNA expression among three groups. Smoking affected surviving mRNA expression as an independent factor. Surviving mRNA expression is correlated with smoking or not, but no correlation with the degree of smoking, Besides smoking factors, survivin mRNA expression in the BALF can be used as a reference in the diagnosis of lung cancer, and surviving mRNA expression is positively correlated with TNM stage, not related with histological type of lung cancer.
出处 《现代中西医结合杂志》 CAS 2013年第24期2623-2625,2628,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 肺肿瘤 支气管肺泡灌洗液 SURVIVIN mRNA 吸烟 lung cancer bronchoalveolar lavage fluid surviving mRNA smoke
  • 相关文献

参考文献14

  • 1Kanwar JR,Kamalapuram SK,Kanwar RK.Targeting survivin in cancer:patent review[J].Expert Opin Ther Pat,2010,20(12):1723-1737.
  • 2Chanvorachote P,Pongrakhananon V,Wannachaiyasit S.Curcumins ensitizes lung cancer cell stocisplat in induced apopt osis through super oxide anion mediated Bcl-2 degradation[J].Cancer Investigation,2009,27(6):250-252.
  • 3Shanghui Zhou,Xingzhou Qu,Zhiwei Yu,et al.Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2010,109:575-581.
  • 4Kelly AE,Ghenoiu C,Xue JZ,et al.Survivin Reads Phosphorylated Histone H3 Threonine 3 to Activatethe Mitotic Kinase Aurora B[J].Science,2010,330(6001):235-239.
  • 5Atlasi Y,Mowla SJ,Ziaee SA.Differential expression of survivin and its splice variants,survivin-DEx3 and survivin-2B,in bladder cancer[J].Cancer Detect Prev,2009,32(4):308-313.
  • 6Krepela E,Dankova P,Moravcikova E,et al.Increased expression of inhibitor of apoptosis proteins,survivin and XIAP,in non small cell lung carcinoma[J].Int J Oncol,2009,35(6):1449-1462.
  • 7Yamashita S,Chujo M,Miyawaki M,et al.Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non small cell lung cancer[J].J Exp Clin Cancer Res,2009,19(28):22.
  • 8Naumnik W,Nilklińska W,Ossolińska M,et al.Serum levels of HMGB1,survivin,and VEGF in patients with advanced non small cell lung cancer during chemotherapy[J].Folia Histochem Cytobiol,2009,47(4):703-709.
  • 9Yie SM,Lou B,Ye SR,et al.Clinical significance of detecting survivin expressing circulating cancer cells in patients with non small cell lung cancer[J].Lung Cancer,2009,63(2):284-290.
  • 10Schmidt B,Weickmann S,Witt C,et al.Integrity of cell free plasma DNA in patients with lung cancer and nonmalignant lung disease[J].Ann N Y Acad Sci,2008,1137:207-213.

二级参考文献19

  • 1Landis SH, Murray T, Bolden S, et al. Cancer statistics 1998. CA Cancer J Clin, 1998, 48: 6-29.
  • 2Mesri M, Wall NR,Li J, et al. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest, 2001,108: 981-990.
  • 3Allen SM, Florell SR, Hanks AN, et al. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Cancer Res , 2003,63: 567-572.
  • 4Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med, 1997,3:917-921.
  • 5Grossman D, McNiff JM, Li F, et al. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest,1999 ,79:1121-1126.
  • 6Sarela AI, Macadam RC, Farmery SM, et al. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut, 2000,46:645-650.
  • 7Johnson DH, Chang AY, Ettinger DS, et al. Recent advances with chemotherapy for NSCLC: the ECOG experience. Eastern Cooperative Oncology Group. Oncology, 1998, 12(1 Suppl 2): 67-70.
  • 8Velculescu VE, Madden SL, Zhang L, et al. Analysis of human transcriptomes. Nat Genet, 1999,23:387-388.
  • 9Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature, 1998,396:580-584.
  • 10Monzo M, Rosell R, Felip E, et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol, 1999 ,17:2100-2104.

共引文献39

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部